Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus InfectionLine K. Vibholm, Ole S. Søgaard, Rasmus Offersen et al.|Clinical Infectious Diseases|2017Cited by 146
Revaccination of patients with systemic lupus erythematosus or rheumatoid arthritis without an initial COVID-19 vaccine response elicits seroconversion in half of the patientsChristian Gytz Ammitzbøll, Anne Troldborg, Marianne Kragh Thomsen et al.|Clinical and Experimental Rheumatology|2023Cited by 3